S.Biomedics Co., Ltd.


Sbiomedics is dedicated to researching and developing cell therapy products through stem cells, focusing on regenerative medicine. The company values each individual's life and aims to provide healthy living and future for families by realizing the limitless possibilities of stem cells. They hold 152 patent applications with 110 patents granted, demonstrating their commitment to innovation in the field.

Industries

biotechnology
pharmaceutical
therapeutics

Nr. of Employees

small (1-50)

S.Biomedics Co., Ltd.

Seoul, Seoul-t'ukpyolsi, South Korea, Asia


Patents

Method for inducing differentiation of stem cell into dopaminergic neural precursor cell

US-11655450-B2

View Details

In vitro fibrosis model, preparing method therefor, and use thereof

US-11365396-B2

View Details

Three-dimensional fibroblast aggregate and in vitro 3D skin dermis model comprising same

US-10725043-B2

View Details

Composition for treating ischemic diseases or neuroinflammatory diseases, comprising secretome of neural precursor cells as active ingredient

US-10688135-B2

View Details

Method for differentiation of stem cells into vascular cells and the induction of angiogenesis using the same

US-9644183-B2

View Details

Method for the immobilization of biologically active polypeptides by using maltose binding protein

US-8669075-B2

View Details
View All Patents

Services

Research and development of cell therapy products derived from stem cells.

Expertise Areas

  • Cell therapy product development
  • Stem cell research
  • Regenerative medicine
  • Intellectual property and patent management

Key Technologies

  • Stem cell-based therapeutics
  • Cellular therapeutics development

News & Updates

Patent Applications and Grants

Sbiomedics has filed 152 patent applications and has 110 patents granted, showcasing their active engagement in innovation and research.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.